9 June 2021Medexus Pharmaceuticals (MDP.V) cuts through supply shortage of injectable drug…Joseph Morton MDP.V Medexus Pharmaceuticals (MDP.V) announced that they’re making their Triamcinolone Hexacetonide (TH) Injectable Suspension, USP (20 mg/ml) available in the United States through the FDA’s CDER Drug Shortage program in…